From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...

Enrollment for liMeliGhT, the first and largest gene therapy registrational trial for broad retinitis pigmentosa (RP) patients, was completed, ...

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...

Retinitis pigmentosa, a degenerative genetic disease of the eye, is characterized by progressive vision loss, usually leading to blindness. In some patients, structural defects in the photoreceptor ...

Ocugen has completed enrollment in liMeliGhT, its phase 3 clinical trial of OCU400 for the treatment of retinitis pigmentosa (RP). The company describes liMeliGhT as a 1-year clinical trial that will ...

Retinitis pigmentosa (RP) is a disease condition that was first identified and named by Dr. Donders in 1857. Retinitis pigmentosa is a group of related conditions that are inherited, progressive and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. At 12 months, data from the phase 1/2 study of AAV5-RPGR ...

THE possibility of losing your sight may sound scary, but there are ways to make your life easier if your eyesight is deteriorating. TV star Amar Latif is a British entrepreneur and presenter who ...

Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering. This report describes and ...

Dublin, April 21, 2025 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa Treatment Market Report and Forecast 2024-2032" has been added to ResearchAndMarkets.com's offering. The retinitis pigmentosa ...

Retinitis pigmentosa is characterised by changes in the pigment layer of the retina. The pigment layer of the retina invades and damages the nerve layer and with time it affects the blood vessels of ...